HNRNPA1P47

Across TCGA pan-cancer cohorts, HNRNPA1P47 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated HNRNPA1P47 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher HNRNPA1P47 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated HNRNPA1P47 expression acts as an unfavorable survival marker, although some lineages such as UCS and SKCM show a favorable association.

STAD, KIRC, and LIHC are the cancer types where HNRNPA1P47 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Quartile	III,IV	0.179	0.713	<.001	41	view →
KIRC	DFS	Median	IV	0.323	0.639	<.001	37	view →
LIHC	OS	Quartile	All	0.638	0.824	<.001	36	view →
UCS	DFS	Median	IV	0.909	0.416	.008	30	view →
SKCM	OS	Median	III,IV	0.940	0.735	.001	24	view →
OV	DFS	Median	IV	0.584	0.363	.007	20	view →
READ	OS	Tertile	IV	0.913	0.481	.010	15	view →
THCA	DFS	Quartile	All	0.971	0.835	.015	11	view →
COAD	DFS	Median	IV	0.335	0.575	.006	9	view →
ACC	OS	Median	III,IV	0.314	0.792	.003	9	view →
SARC	OS	Quartile	All	0.349	0.533	.016	7	view →
LUAD	DFS	Median	IV	0.753	0.332	.034	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

HNRNPA1P47–STAD (DFS)

Open the STAD breakdown →